Oral lipid supplements for treating pain and fibromyalgia
US10874681B2 · kind B2 · utility
0Cited by
20References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 29, 2018 |
| Grant date | Dec 29, 2020 |
| Priority date | — |
| Expiry date | Oct 29, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of oral delivery of phospholipid/inulin compositions comprising capsules, tablets, chewable wafers or powdered material in a liquid carrier in quantities effective for treating systemic pain from fibromyalgia. The compositions further including effective amounts of caffeine also reduces fatigue and enhances alertness and focus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.